34967-25-4

Basic information

• Product Name: 3,5-dimethoxybenzaldoxime
• Synonyms: 3,5-dimethoxybenzaldoxime
• CAS NO: 34967-25-4
• Molecular Weight: 181.191
• Mol File: 34967-25-4.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: 3,5-dimethoxybenzaldoxime(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-dimethoxybenzaldoxime(34967-25-4)
• EPA Substance Registry System: 3,5-dimethoxybenzaldoxime(34967-25-4)

Safety Data

• Hazardous Substances Data: 34967-25-4(Hazardous Substances Data)

Upstream product

• 7311-34-4 3,5-dimethoxybenzaldehdye 
• 34967-24-3 3,5-dimethoxybenzylamine 

Downstream Products

• 26994-73-0 3,5-dimethoxy-benzaldehyde (E)-O-(1,1-dioxo-1H-1λ⁶-benzo[d]isothiazol-3-yl)-oxime 
• 34967-24-3 3,5-dimethoxybenzylamine 
• 7311-34-4 3,5-dimethoxybenzaldehdye 
• 90817-33-7 3,5-dihydroxybenzylamine 
• 53389-74-5 N-Chloracetyl-3,5-dihydroxy-benzylamin 
• 647860-07-9 1-(3',5'-dimethoxyphenyl)but-3-en-1-ol 
• 19179-31-8 3,5-dimethoxy-benzonitrile 
• 165459-69-8 (3,5-dimethoxyphenyl)isonitrile 

Relevant articles and documents

1,3-dipolar cycloaddition reactions of the compound obtaining from cyclopentadiene-PTAD and biological activities of adducts formed selectively

After known adduct (4) was synthesized by cycloaddition reaction of cyclopentadiene with 4-phenyl-1,2,4-triazoline-3,5-dione, seven new isoxazoline derivatives were synthesized from reactions of 4 with corresponding oximes prepared from benzaldehyde derivatives in the existence of the aqueous NaOCl in CH2Cl2 at 0°C—RT via nitrile oxides. Four new pyrazoline derivatives were also synthesized from reactions of 4 with corresponding prepared reagents via nitrile imines. Selectively, each of all isoxazole and pyrazoline derivatives was synthesized by 1,3-dipolar cycloaddition reactions of compound 4 with the corresponding reagents. Based on the results of their biological activity analyses, Ki values for acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and alpha-glucosidase (α-Gly) enzymes were obtained in this range 32.15 ± 5.73–107.44 ± 19.52 22.57 ± 4.30–186.07 ± 23.51, and 69.08 ± 8.54–528.07 ± 38.46 nM, respectively. Besides that, these compounds were subjected to molecular docking to describe the interaction against AChE, BChE, and α-Gly enzymes in which important interactions were visualized and evaluated with residues of the binding region in each target enzyme.

One-Pot Regioselective Synthesis of 7-Bromo-2H-Benzo[b][1,4]Oxazin-3(4H)-One Linked Isoxazole Hybrids as Anti-Cancer Agents and Their Molecular Docking Studies

Abstract: Regioselective synthesis of some novel 7-bromo-2H-benzo[b][1,4]oxazin-3(4H)-one linked isoxazole hybrids via copper(I) catalyzed one-pot reaction of various aromatic aldehydes with 7-bromo-4-(prop-2-yn-1-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one was developed. The structures of the compounds that are synthesized are confirmed by 1H NMR, 13C NMR, and mass spectra. All the hybrids have been tested for their in vitro anticancer activity against four human cancer cell lines, including HeLa, MCF-7, A549, and PC3. Three of the compounds exhibited remarkable anticancer activity compared to standard drug etoposide. Molecular docking studies with EGFR also strengthened the in vitro anticancer activity.

Iron-catalyzed synthesis of benzoxazoles by oxidative coupling/cyclization of phenol derivatives with benzoyl aldehyde oximes

An iron-catalyzed oxidative coupling/cyclization reaction for the synthesis of benzoxazoles at room temperature is reported. This reaction was enabled by an inexpensive iron(iii) catalyst by treating readily available phenol derivatives with benzoyl aldehyde oximes. Mechanistic studies show that benzoyl aldehyde oxime is not only used as a substrate, but also serves as an ancillary ligand to support the iron salt in the promotion of the transformation.